ePT--the Electronic Newsletter of Pharmaceutical Technology, Dec 6, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
ePT--the Electronic Newsletter of Pharmaceutical Technology, Dec 6, 2012
News
Ranbaxy Issues Voluntary Recall of Atorvastatin Due to Quality Issues
By Patricia Van Arnum
The company issues voluntary recall of certain lots due to possible contamination with small glass particles.
EMA Publishes Plan to Deal with Supply Shortages
By Stephanie Sutton
The European Medicines Agency has published a plan to help Europe?s regulatory network prevent, mitigate and manage shortages of important medicines following manufacturing problems.
US Supreme Court to Hear Myriad Genetics' Gene Patentability Case
By Patricia Van Arnum
Myriad Genetics reports that the US Supreme Court has granted certiorari agreeing to hear the company's gene patentability case.
Lilly Releases Corporate Responsibility Update
By Amy Ritter
Eli Lilly released its annual report containing updates on progress and new initiatives in corporate responsibility.
Week of December 3, 2012: Biogen Idec Opens New RTP Facility; Tekmira, Marina Biotech Enter into License Agreement for UNA Technology; and More
Biogen Idec Opens New RTP Facility; Tekmira, Marina Biotech Enter into License Agreement for UNA Technology; and More.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Click here